chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had a bad reaction; Something that looked like the measles but instead of being red, they were white looking; Diarrhea; Some aches and pains; Throwing up; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Had a bad reaction), RASH MORBILLIFORM (Something that looked like the measles but instead of being red, they were white looking), DIARRHOEA (Diarrhea), PAIN (Some aches and pains) and VOMITING (Throwing up) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. NWKDOH) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION COMPLICATION (Had a bad reaction), RASH MORBILLIFORM (Something that looked like the measles but instead of being red, they were white looking), DIARRHOEA (Diarrhea), PAIN (Some aches and pains), VOMITING (Throwing up) and NAUSEA (Nausea). At the time of the report, VACCINATION COMPLICATION (Had a bad reaction), RASH MORBILLIFORM (Something that looked like the measles but instead of being red, they were white looking), DIARRHOEA (Diarrhea), PAIN (Some aches and pains), VOMITING (Throwing up) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Patient called regarding a different issue, then states she had a reaction to the PREVNAR 13 vaccination of redness and swelling from her shoulder down to her hand of the Left arm/forearm. States it has since resolved. Pt was given vaccination on 5/2/18 and I spoke with pt on 5/8/18, which is when she informed me of the adverse reaction. The vaccination was added to her allergies/rxn list, provider was notified. The vaccination adverse reaction is currently being reported.
I63.9 ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 12/10/2021 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED
Loss of taste; Some white spots on hid tongue; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Loss of taste) and TONGUE DISCOLOURATION (Some white spots on hid tongue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AGEUSIA (Loss of taste) and TONGUE DISCOLOURATION (Some white spots on hid tongue). At the time of the report, AGEUSIA (Loss of taste) and TONGUE DISCOLOURATION (Some white spots on hid tongue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The concomitant medications were not reported.  The treatment information was not provided.   Reporter did not allow further contact
Information has been received from a registered nurse concerning a 42 year old male with a history of bipolor disorder and drug induced thrombocytopenia who on 28-JAN-1999 was vaccinated with PNEUMOVAX 23. On 11-FEB-1999 the patient was administered immune globulin human and meningitis vaccine. Concomitant therapy included prednisone, lithium citrate, PROLASTIN, and  ARTANE. On 28-FEB-1999 the patient was diagnosed with BELL' Palsy and was hospitalized. No further information is available.
Information has been received from a nurse concerning a 74 year old caucasian male who in the morning on 10/22/2004 was vaccinated intramuscularly in the left deltoid with a 0.5ml second dose of pneumococcal 23v polysaccharide vaccine (lot 649989/0579P).  Three to four days post vaccination, the patient had severe reactions to the vaccine with the development of chills, fever, trembling, numbness, tingling, redness and swelling (also reported that there was no redness or swelling) in the vaccinated limb; and nerve pain down his arm about two inches from the injections site.  The patient also lost some range of motion in the vaccinated arm.  Unspecified medical attention was sought.  The patient's outcome was not reported.  Follow up information from a registered nurse indicated that on 10/22/2004 the patient developed myalgia, extreme pain below the injection site- radiating into fingers, chills and he was unable to raise his arm.  It was reported that the patient recovered from myalgia, extreme pain below the injection site- radiating into fingers, chills and unable to raise his arm on 10/26/2004.  The records of testing prior to release of this lot have been checked and found to be satisfactory.  The lot complies with industry standards and was released.  It was also reported that 3 other patients had adverse experiences following administration of pneumococcal 23v polysaccharide vaccine.  Additional information has been requested.
Pt reported these reaction symptoms: shortness of breath, chest tightness, heart palpitations, irregular heart beats, tachycardia, malaise, extreme scalp itchiness and scalp flaking
Client was feeling generally weak, off balance and chilled starting on 5/1. Subsequently, he developed body aches and a non productive cough. He has no sore throat, chest pain, or shortness of breath. On 5/4 the client presented to the emergency department with generalized weakness, lightheadedness, chills, cough, and fever. He received Tylenol and IV fluids while in the ER. Covid test was negative. Client admitted to hospital for further evaluation.
Rushed to ER and diagnosed with neuropathy; Pain; Skin sensitivity; Occasionally face feels like water is being splashed on it; not able to sleep for 11 days because of her symptoms; Chills; A spontaneous report was received from a consumer concerning for herself, a 44-year-old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events Rushed to ER and diagnosed with neuropathy(/neuropathy peripheral), chills (chills), pain (pain), Skin sensitivity/(skin sensation), Unable to sleep for 11 days because of her symptoms (Insomnia) and Occasionally face feels like water is being splashed on it /(Facial discomfort).  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On 23 Feb 2021, prior to the onset of the events, the patient received hertheir first of the two planned vaccine doses of mRNA-1273 (Batch/Lot number: 001A21A) via intramuscularly for the prophylaxis of COVID-19 infection.  On 02 Mar 2021, the patient was rushed to ER for tingling and numbness she developed in her feet, up to  the leg and on her hand and got diagnosed as Neuropathy which was medically significant. The patient experienced chills, pain, skin sensitivity and numbness in feet/legs, sometimes in hands. Occasionally face "feels like water is being splashed on it". These symptoms have occurred for 11 days. Patient was rushed to ER for tingling and numbness she developed in her feet, up to the leg and on her hand and got diagnosed as Neuropathy. She was not able to sleep for 11 days because of her symptoms. Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was unknown.  The outcomes of the events, Rushed to ER and diagnosed with neuropathy, chills, pain, Skin sensitivity, unable to sleep for 11 because of her symptoms and occasionally face feels like water is being splashed on it, were unknown at the time of this report.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Seconds after receiving the second dose of the Pfizer vaccine, patient complained of headache and stomachache and lightheadedness. Patient's eyes rolled and he became limp. Patient's mother and the pharmacist helped him to the floor, and he regained consciousness seconds later. He was given water and a granola bar and said he felt better after a few minutes. This adverse effect did not occur with the first dose.
Information has been received from a registered nurse reporting on a patient of unknown age and gender. There was no information about the patient's concurrent conditions, drug reactions/allergies or medical history. The patient's concomitant medication included sterile diluent. On 28-DEC-2017, the patient received an improperly stored dose of PROQUAD for prophylaxis (dose, route of administration, lot number and expiration date were not reported). No adverse effect reported. It was reported that on an unspecified date, the vaccine was exposed to a temperature between -9° Celsius degrees and 8 Celsius degrees for 2 hours and 40 minutes. There was no previous temperature excursion. The call was placed because of a Digital Data logger report.
About a week and a half after I received the first shot a large, itchy, red lump appeared at the injection site. It was also very sore and tender to touch. It went away after 3 days. Then 3-4 after that I developed a hives like rash on my neck and upper chest area, which I still currently have.
This spontaneous report was received from a back office lead and refers to a 54 year old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 02-JAN-2016, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB lot # L038499, expiration date: 26-JUN-2017, 1 ml, intramuscularly, in right deltoid (dose number was not provided). There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
nausea; site was red and very large, round and hard; stomach cramp and felt like throwing up; itchiness around the site; red around the site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red around the site), NAUSEA (nausea), VACCINATION SITE INDURATION (site was red and very large, round and hard), ABDOMINAL PAIN UPPER (stomach cramp and felt like throwing up) and VACCINATION SITE PRURITUS (itchiness around the site) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA), AZELASTINE, MONTELUKAST SODIUM and BUDESONIDE (PULMICORT) for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (red around the site), VACCINATION SITE INDURATION (site was red and very large, round and hard), ABDOMINAL PAIN UPPER (stomach cramp and felt like throwing up) and VACCINATION SITE PRURITUS (itchiness around the site). On 03-Mar-2021, the patient experienced NAUSEA (nausea). The patient was treated with TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE (GLUCOCORTICOID)) for Adverse event, at a dose of 0.025 %. At the time of the report, VACCINATION SITE ERYTHEMA (red around the site), NAUSEA (nausea), VACCINATION SITE INDURATION (site was red and very large, round and hard), ABDOMINAL PAIN UPPER (stomach cramp and felt like throwing up) and VACCINATION SITE PRURITUS (itchiness around the site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
7JUL98 devel redness, swelling & tenderness localized 3"x3" area to rt deltoid eval @ clinic 9JUL98;13JUL98 cellulitis w/I&D of approx 150cc purulent drainage-afeb;
Moderna bivalent COVID booster vaccine given to 16 year-old patient, unaware that it is only approved for those over 18 years old
This spontaneous report as received from a pharmacist refers to a 51 year old female patient. The patient had no pertinent medical history and no drug reactions or allergies. On 13-FEB-2016, the patient was vaccinated with a dose of ZOSTAVAX subcutaneously, 0.65 ml, lot # L016284, expiration date 07-AUG-2016 (dose number and anatomical location were not reported) (also reported as the vaccination was recommended by physician, prescription written). The patient did not take any concomitant medications. On approximately 17-FEB-2016 (reported as 4 to 5 days after receiving ZOSTAVAX), the patient experienced rash on her legs, which spread to her torso and swelling at the injection site. The patient sought medical attention as she was seen by her physician (on an unknown date) and was prescribed prednisone (manufacturer unknown) (route of administration, dosage, lot number and expiration date were not reported) as treatment for the rash. The patient was additionally prescribed an unspecified antihistamine medication (route of administration, dosage, lot number and expiration date were not reported) for an unspecified reason. No lab diagnostic studies were performed. Product quality complaint was not involved. The outcome of rash and swelling at the injection site was not reported. The relatedness between the events and ZOSTAVAX was not reported. Additional information has been requested.
Approx. 2x2: painful, red, warm, raised area at injection site; Approx. 2x2: painful, red, warm, raised area at injection site; Approx. 2x2: painful, red, warm, raised area at injection site; This is a spontaneous report from a contactable nurse (patient herself). A 29-year-old female patient received two doses of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), first dose on 18Dec2020 (lot number: EK5730) and second dose on 08Jan2021 (lot number: EK9231), both intramuscular in the left arm (injection placed approximately 8" below acromion process, medial side of arm, not into deltoid) at single dose for COVID-19 immunization. Medical history included asthma and covid (reported as "if covid prior vaccination: Yes"). The patient is not pregnant. Concomitant medications included montelukast sodium (SINGULAIR), sertraline hydrochloride (ZOLOFT), and melatonin. The patient previously took phenytoin sodium (DILANTIN) and carbamazepine (TEGRETOL), and both experienced with known allergies. The patient had not tested for COVID post vaccination. The patient experienced approx. 2x2: painful, red, warm, raised area at injection site on 09Jan2021 04:00. No treatment received for these events. The outcome of the events was recovering.
Patient saw a PA in our clinic with tapezius muscle tenderness, diagnosed with Cervicalgia on 3/30/21,.  did not report he had at vaccination at time of appointment, came by later to amend this report.
child c/o sore arm Monday pm mom noticed swelling on 6FEB96;7FEB96 to be checked;lt arm swollen & red pt c/o pain;no temp;APAP given, rest arm, use warm/wet or cold packs per child comfort;go to ER if s/s worsen;8FEB96 recheck using arm
I started having flu like symptoms fatigue and body aches, severe actually.  It was diffucult to move from bed to barthroom.  I thought it would go within a few days but it did not, I then began to have pain in my left ear at that point I decided to go to doctor so I went to an Urgent care clinic. I was seen by a doctor and was advised to take fluids including takng a pain killer. In four to five days I saw no difference and so I went again to the doctor and at this time I was prescribed an antibiotic for th infection in my ear.  After starting the antibiotic not being comfortable with the treatment I went  to an ENT docotor he said I had fluid in my ear and more antibiotics were prescribed after which in three months it cleared.
Approximately 10 minutes after administration of varicella vaccine in left thigh, mother drew my attention to a red, mottled rash around injection site approximately 1.5" wide and 1" long. Rash remained.
temp 106F and sz. taken to Hosp. 12/8-12/9/83. child recovered.recent dental exam revealed dental deformity.
Patient received first dose of vaccine at 0940 am.  At 0945 patient complained  of feeling  like having difficulty swallowing to Observation nurse, Dr. with patient. Patient was given Epinephrine via Quick-Dose Pen in left thigh.  Patient connected to monitor and B/P 179/90, HR 117, RR 22, pulse ox 99.   At 0950 patient states she is beginning to feel a bit better, swallowing a bit easier.   0955 Rapid Response Team called and notified of situation. ER charge nurse notified of  situation.    1005  B/P 170/88, HR 99 RR 22 pulse ox 100.  Patient given Benadry 50 mg po by RN. 1015 Patient states her swallowing is again becoming more difficult.  Given second dose Epinephrine via Quick-Pen by RN.   Rapid  Response Team arrived and assumed care.  ED charge RN notified of patient status.
Bilateral arm & leg parasthesias, headache, mild shortness of breath all started Dr. sent patient to E.R. for MRI. Parasthesias improved and resolved over several days, but changed to bilateral leg weakness and muscle soreness which continue to this date. Shortness of breath lasted only first day. On 10/16 and 17 patient had a feeling of neck pressure, worsening when she lied flat on back, now resolved. Daily headaches continue. 11/9/09 Vaccination record received and updated. 11/30/09:  ED record received for date of service 10/15/09.  Dx:  Paresthesia.  C/O gradual onset of intermittent numbness of bilateral arms and legs with hot and cold flashes.  Most prominent from knees down lower leg.  Intermittent dizziness, ambulates with steady gait.  Discharged home, condition stable.
Fever; Sick feeling; Covid arm; Lethargic; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PYREXIA (Fever), MALAISE (Sick feeling), VACCINATION SITE REACTION (Covid arm) and LETHARGY (Lethargic) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     Concurrent medical conditions included Insomnia and Drug allergy. Concomitant products included ZOLPIDEM TARTRATE (AMBIEN) from 01-Jan-2015 to an unknown date for Insomnia, VITAMINS NOS and IBUPROFEN (ADVIL [IBUPROFEN]) for an unknown indication.    On 20-Feb-2021 at 11:15 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced PYREXIA (Fever) and LETHARGY (Lethargic). 20-Feb-2021, the patient experienced MALAISE (Sick feeling) and VACCINATION SITE REACTION (Covid arm). On 25-Feb-2021, PYREXIA (Fever), MALAISE (Sick feeling), VACCINATION SITE REACTION (Covid arm) and LETHARGY (Lethargic) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Specific treatment information was not reported.   This case was linked to MOD-2021-018071 (Patient Link).
On approximately 11/25/99, the pt experienced a blister like reaction "which looks like chicken pox." It was noted that the pt experienced a similar reaction after the first and second doses of Hep B vaccine. These reactions occurred within 1-2 days after immunization. The pt sought unspecified medical treatment. Medrol was prescribed for one week for this recent episode. Additional information has been requested.
About 30 seconds after administering  the vaccine the patient began to feel light headed. About a minute after  the first symptoms started, the patient lost  consciousness for about 20-30 seconds. I provided support for  about 20 minutes and he recovered without complications. I walked with him to the store exit and he walked un-aided the entire way. Situation resolved without incident. The patient had also stated that he had fainted upon receiving another vaccine in the past  (meningitis vaccine) he did not know which one.
Her arm hurt for about a week; This is a spontaneous report from a contactable consumer (patient). A 67-years-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EJ1685, expiration date: unknown), via an unspecified route of administration on the right arm on 28Dec2020 at a single dose for COVID-19 immunization. Medical history included ongoing blood pressure high, ongoing diabetes, ongoing hypothyroidism, high cholesterol and allergy. Concomitant medications included mometasone furoate (FLONASE [MOMETASONE FUROATE]) and montelukast sodium (SINGULAIR) - both ongoing and for allergy. No other vaccines administered on the same date with the Pfizer vaccine. The patient stated that she did okay with the first dose, and her arm hurt for about a week on an unspecified date. The outcome of the event was unknown.
got really really sick; more than 35 days from 1st vaccination; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got really really sick) and PRODUCT DOSE OMISSION ISSUE (more than 35 days from 1st vaccination) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced ILLNESS (got really really sick) and PRODUCT DOSE OMISSION ISSUE (more than 35 days from 1st vaccination). At the time of the report, ILLNESS (got really really sick) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (more than 35 days from 1st vaccination) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
Rapid irregular heart rate. PVCs  body aches and headache hoarsness and shortness of breath due to the PVC...lasted on into midnite and went to ER...Took Tylenol and Xanax
Case number PHEH2015US026939, is an initial spontaneous report received from a nurse on 22 Dec 2015. This report refers to a 22 years old male patient. Past medical history and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1514501 and expiry date: May 2016) in left deltoid on 19 Oct 2015. It was reported that before administration the FLUVIRIN had a temperature excursion of 34 degrees. The reporter stated that she did not know why the refrigerator was out of temperature range for an unspecified amount of time overnight. She checked the temperature before she left for the day and when she arrived the next day and the temperature was fine. It was a new refrigerator and there have not been any problems since the temperature excursion. No adverse reaction was experienced by the patient following the maladministration. No further information was provided. Follow up information received from the nurse on 26 Jan 2016: Reporter's comment updated.
I tested positive for COVID-19 on 12/1 and had very few symptoms. A mild headache for the first few days. Then on Thursday 12/8 I started having asthma and respiratory symptoms. Not bad, mild to moderate, but I contacted my doctor and used my inhaler every 4-6 hours. Yesterday and today the breathing has been easier, but I am still testing positive via antigen test. The only other symptom I've had is fatigue, which I still have. I have not been as asthmatic, I've only used my inhaler once a day,  but I still have respiratory symptoms, you can hear it in my voice.